Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer

Clinical trial NCT00364754 · COMPLETED

Trial details

NCT number: NCT00364754
Sponsor: YM BioSciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic/Recurrent Breast Cancer

Start date: 2004-05-01
Primary completion: 2006-01-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.